Dr. Eric L. Cottrill, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (1980)
- Years since graduation
- 46
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 309
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1980Medical school: University of Oklahoma College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
OK license 13194
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Saint Francis Hospital, Inc Tulsa, OK
- Saint Francis Hospital South, LLC Tulsa, OK
- Saint Francis Hospital Muskogee Muskogee, OK
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 309
- Services billed
- 962
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 193 | 165 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 181 | 158 |
| Established patient office or other outpatient visit, 10-19 minutes | 104 | 92 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 76 | 56 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | 65 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 61 | 31 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 55 | 55 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | 43 |
| Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | 22 | 20 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dexlansoprazole Dr (dexlansoprazole) Other prescribers in Tulsa, OK | 351 |
| Esomeprazole Magnesium Other prescribers in Tulsa, OK | 244 |
| Sucralfate Other prescribers in Tulsa, OK | 175 |
| Omeprazole Other prescribers in Tulsa, OK | 108 |
| Plenvu (peg3350/sod sul/nacl/kcl/asb/c) | 30 |
| Mesalamine Other prescribers in Tulsa, OK | 25 |
| Pantoprazole Sodium Other prescribers in Tulsa, OK | 24 |
| Ondansetron Odt (ondansetron) Other prescribers in Tulsa, OK | 21 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Tulsa, OK | 18 |
| Suflave (peg 3350/sod sulf,chlr/pot/mag) | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 11 payments worth $195 in total to this clinician.
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.16 |
|---|---|
| Gilead Sciences, Inc. | $41.51 |
| Madrigal Pharmaceuticals | $27.91 |
| AbbVie Inc. | $19.12 |
| Pfizer Inc. | $15.57 |
| Phathom Pharmaceuticals, Inc. | $12.81 |
| Food and Beverage | $195 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.